Evidence map›Paper›PMID 38694292›Full record

ArticleAnnals of medicine and surgery (2012)2024

Survival analysis and prognostic model establishment of secondary osteosarcoma: a SEER-based study.

Jing Wang, Gongbo Fu, Zhongxiu Zhu, Lan Ding, Yitian Chen, Huiyu Li, Dan Xiang, Zhe Dai, Jialong Zhu, Linlin Ji and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Jing WangDepartment of Oncology, Jinling Clinical Medical College.
Gongbo FuDepartment of Oncology, Jinling Clinical Medical College.
Zhongxiu ZhuDepartment of Gastrointestinal Surgery, Jiangsu Cancer Hospital, Nanjing Medical University.
Lan DingResearch Institute of General Surgery, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University.
Yitian ChenDepartment of Oncology.
Huiyu LiDepartment of Oncology.
Dan XiangDepartment of Oncology.
Zhe DaiDepartment of Oncology.
Jialong ZhuDepartment of Oncology.
Linlin JiDepartment of Oncology.
Zengjie LeiDepartment of Oncology, Jinling Clinical Medical College.
Xiaoyuan ChuDepartment of Oncology, Jinling Clinical Medical College.
Nanjing General Hospital of Nanjing Military Command · CNNanjing University of Chinese Medicine · CNFirst Consulting Group (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Surgical excision is considered one of the most effective treatments for secondary osteosarcoma (SO). It remains unclear whether the survival of patients with secondary osteosarcoma (SO) could be associated with their surgical willingness. Materials and methods: The statistics of the patients diagnosed with SO between 1975 and 2008 were gathered from the surveillance epidemiology and end results (SEER) database. The patients were divided into three subgroups according to their surgical compliance. The authors used the multivariable Logistic regression analysis and cox regression method to reveal the influence of surgical compliance on prognosis and the risk factors of surgical compliance. Additionally, the authors formulated a nomogram model to predict the overall survival (OS) of patients. The concordance index (C-index) was used to evaluate the accuracy and practicability of the above prediction model. Results: Sixty-three (9.2%) of the 688 patients with SO who were recommended for surgical treatment refused to undergo surgery. Lower surgical compliance can be ascribed to an earlier time of diagnosis and refusal of chemotherapy. The lower overall survival (OS) {[hazard ratio (HR)] 1.733, [CI] 1.205-2.494, Conclusions: Surgical compliance was proved to be an independent prognostic factor in the survival of patients with SO.

Indexed as

Nomogramoverall survival (OS)secondary osteosarcoma (SO)SEERsurgical compliance

Identifiers

PMID38694292
PMCPMC11060285
OpenAlexW4392810451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.